Gabriel Morin

Alpelisib administration reduced lymphatic malformations in a mouse model and in patients

B. Bonnotte, G. Canaud, O. Boccara, 2021, Science Translational Medicine.

Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib

N. Boddaert, G. Canaud, F. Branle, 2022, The Journal of experimental medicine.

PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption

B. Tavitian, M. Polak, G. Canaud, 2022, Science advances.

Treatment strategies for mosaic overgrowth syndromes of the PI3K-AKT-mTOR pathway.

G. Canaud, Gabriel Morin, 2021, British medical bulletin.

COVID-19 in Patients on Maintenance Dialysis in the Paris Region

R. Snanoudj, S. Beaudreuil, C. Legendre, 2020, Kidney International Reports.

Management of post-transplant recurrent focal and segmental glomerulosclerosis.

G. Canaud, C. Legendre, Gabriel Morin, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.